The FDA has placed an import warning on the Gujarat facility of an Indian pharmaceutical company . The notice indicates that until the facility complies with the FDAs Current Good Manufacturing Practice guidelines, the US market may refuse to accept any shipments of products created at Halol in the future .
Bengaluru: Sun Pharmaceutical Industries Ltd today announced that the US Food and Drug Administration (FDA) has placed an import warning on the Gujarat facility of an Indian pharmaceutical company.The import notice indicates that until the facility complies with the FDA's Current Good Manufacturing Practice guidelines, the US market may refuse to accept any shipments of products created at Halol in the future, the business said.